Quick Takeaways
- This page summarizes Brian Corvese's Form 4 filing for AGENUS INC (AGEN).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 08 Feb 2022, 17:12.
Brian Corvese - 04 Feb 2022 Form 4 Insider Report for AGENUS INC (AGEN)
- Role
- Director
- Signature
- By: /s/ Christine Klaskin as Attorney-in-Fact for Brian Corvese
- Issuer symbol
- AGEN
- Transactions as of
- 04 Feb 2022
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 08 Feb 2022, 17:12:06 UTC
- Previous filing
- 20 Oct 2021
- Next filing
- 11 Mar 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"Brian Corvese filed Form 4 for AGENUS INC (AGEN) on 08 Feb 2022."
What Changed
- Previous filing in this sequence was filed on 20 Oct 2021.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
AGEN
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +150,000
- Change %
- Price
- $0.000000
- Shares after
- 150,000
- Date
- 04 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 150,000
- Exercise price
- $2.39
- Footnotes
- F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan, as amended, and will vest on February 4, 2023. |